Median Technologies: Median Strengthens its iBiopsy Leadership Team With the Appointment of Thomas Bonnefont as Chief Operating and Commercial Officer and the Appointment of Mike Doherty as Sr. Strategy Advisor, Product Development
(2) These two appointments follow a series of first successful achievements for iBiopsy in 2020 and early 2021. Median prepares to launch its iBiopsy product development plan, including regulatory aspects, define its go-to-market strategy then expand its iBiopsy operations globally. Regulatory News: Thomas Bonnefont (Photo: Median Technologies) Median Technologies (ALMDT:PA) (Paris:ALMDT) announced today the appointment of Thomas Bonnefont to the newly created position of Chief Operating and Commercial Officer of the iBiopsy Business Unit as well as the appointment of Mike Doherty as Sr. Stra...